We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00184691
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : January 18, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S